Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models ; volume:14 ; number:1 ; day:11 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.7.2024), 1-11, 12.2024
- Creator
-
Pogorzelska, A.
Świtalska, M.
Wietrzyk, J.
Mazur, M.
Milczarek, M.
Medyńska, K.
Wiktorska, K.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-65455-w
- URN
-
urn:nbn:de:101:1-2409282113467.652999788930
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pogorzelska, A.
- Świtalska, M.
- Wietrzyk, J.
- Mazur, M.
- Milczarek, M.
- Medyńska, K.
- Wiktorska, K.
- SpringerLink (Online service)
Other Objects (12)
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells
IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
A recent overview on sulforaphane as a dietary epigenetic modulator
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer